12 daytime (acetaminophen 250 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Capsule) / 8 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule) Pack

{12 (acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 8 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack

{12 (acetaminophen 250 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Capsule) / 8 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG Oral Capsule) } Pack

12 daytime (acetaminophen 250 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Capsule) / 8 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Capsule) Pack


{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Aurovela Fe 24 1/20 28 Day]


{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Aurovela 1.5/30 21 Day]


adalimumab starter pack 80 MG/0.8 mL Auto-Injector (3 count)

{3 (0.8 ML adalimumab 100 MG/ML Auto-Injector) } Pack

adalimumab starter pack 80 MG/0.8 ML Auto-Injector (3 count)


allantoin 0.2 % / menthol 0.5 % Topical Gel

allantoin 0.002 MG/MG / menthol 0.005 MG/MG Topical Gel


Aconitum carmichaelii lateral root extract


menthol 10 % / methyl salicylate 10 % Topical Cream

menthol 100 MG/ML / methyl salicylate 100 MG/ML Topical Cream


Bavencio 200 MG per 10 ML Injection
10 ML Bavencio 20 MG/ML Injection
BAVENCIO 200 MG in 10 ML Injection

10 ML avelumab 20 MG/ML Injection [Bavencio]


chlorhexidine / salicyloyl phytosphingosine Shampoo Product


chlorhexidine / salicyloyl phytosphingosine Medicated Shampoo


chlorhexidine gluconate 4 % / salicyloyl phytosphingosine 0.05 % Medicated Shampoo

chlorhexidine gluconate 40 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML Medicated Shampoo


Xadago 50 MG (as safinamide mesylate 65.88 MG) Oral Tablet


niraparib (as niraparib tosylate) 100 MG Oral Capsule


levETIRAcetam 1000 MG Oral Tablet [Roweepra]

levetiracetam 1000 MG Oral Tablet [Roweepra]


levETIRAcetam 250 MG Oral Tablet [Roweepra]

levetiracetam 250 MG Oral Tablet [Roweepra]


levETIRAcetam 750 MG Oral Tablet [Roweepra]

levetiracetam 750 MG Oral Tablet [Roweepra]


levETIRAcetam Extended Release Oral Tablet [Roweepra]

levetiracetam Extended Release Oral Tablet [Roweepra]


24 HR Roweepra 750 MG Extended Release Oral Tablet

ROWEEPRA XR 750 MG 24HR Extended Release Oral Tablet

24 HR levETIRAcetam 750 MG Extended Release Oral Tablet [Roweepra]

Roweepra 750 MG 24 HR Extended Release Oral Tablet

24 HR levetiracetam 750 MG Extended Release Oral Tablet [Roweepra]


24 HR Roweepra 500 MG Extended Release Oral Tablet

ROWEEPRA XR 500 MG 24HR Extended Release Oral Tablet

24 HR levETIRAcetam 500 MG Extended Release Oral Tablet [Roweepra]

Roweepra 500 MG 24 HR Extended Release Oral Tablet

24 HR levetiracetam 500 MG Extended Release Oral Tablet [Roweepra]


naldemedine (as naldemedine tosylate) 0.2 MG Oral Tablet


safinamide 100 MG (as safinamide mesylate 131.76 MG) Oral Tablet


chlorhexidine / miconazole / salicyloyl phytosphingosine Shampoo Product


chlorhexidine / miconazole / salicyloyl phytosphingosine Medicated Shampoo


chlorhexidine / miconazole / salicyloyl phytosphingosine


chlorhexidine gluconate 2 % / miconazole nitrate 2 % / salicyloyl phytosphingosine 0.05 % Medicated Shampoo

chlorhexidine gluconate 20 MG/ML / miconazole nitrate 20 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML Medicated Shampoo


chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG per 5 ML Oral Solution

chlorpheniramine maleate 0.4 MG/mL / phenylephrine HCl 1 MG/mL Oral Solution

chlorpheniramine maleate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution


Pueraria candollei var. mirifica root extract


etelcalcetide 5 MG/ML per 2 ML Injection


Parsabiv 10 MG per 2 ML Injection
Parsabiv 10 MG in 2 ML Injection
Parsabiv 5 MG/ML per 2 ML Injection

2 ML etelcalcetide 5 MG/ML Injection [Parsabiv]


etelcalcetide 5 MG per 1 ML Injection
etelcalcetide 5 MG in 1 ML Injection


Parsabiv 5 MG per 1 ML Injection
Parsabiv 5 MG/ML per 1 ML Injection
Parsabiv 5 MG in 1 ML Injection

1 ML etelcalcetide 5 MG/ML Injection [Parsabiv]


etelcalcetide 2.5 MG per 0.5 ML Injection

etelcalcetide 2.5 MG in 0.5 ML Injection

etelcalcetide 5 MG/ML per 0.5 ML Injection


benzethonium chloride 0.12 % Topical Spray

benzethonium chloride 1.2 MG/ML Topical Spray


sodium nitroprusside 0.5 MG/ML [Nipride]


Nipride 0.5 MG/ML per 100 ML Injection
Nipride 50 MG per 100 ML Injection
NIPRIDE RTU 50 MG in 100 ML Injection

100 ML sodium nitroprusside 0.5 MG/ML Injection [Nipride]


ocrelizumab 300 MG in 10 ML Injection
ocrelizumab 300 MG per 10 ML Injection


Ocrevus 300 MG in 10 ML Injection
10 ML Ocrevus 30 MG/ML Injection
Ocrevus 300 MG per 10 ML Injection

10 ML ocrelizumab 30 MG/ML Injection [Ocrevus]


benzethonium chloride 1.2 MG/ML [NoRisc]


NoRisc 1.2 MG/ML Topical Spray
NoRisc 0.12 % Topical Spray

benzethonium chloride 1.2 MG/ML Topical Spray [NoRisc]


NoRisc 2 MG/ML Topical Cream
NoRisc 0.2 % Topical Cream

benzethonium chloride 2 MG/ML Topical Cream [NoRisc]


{7 (ethinyl estradiol 0.01 MG Oral Tablet) / 42 (ethinyl estradiol 0.02 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.025 MG / levonorgestrel 0.15 MG Oral Tablet) / 21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack [Rivelsa 91 Day]


dupilumab 300 MG per 2 ML Prefilled Syringe

dupilumab 300 MG in 2 ML Prefilled Syringe

2 ML dupilumab 150 MG/ML Prefilled Syringe


2 ML dupilumab 150 MG/ML Prefilled Syringe [Dupixent]

Dupixent 300 MG per 2 ML Prefilled Syringe

DUPIXENT 300 MG in 2 ML Prefilled Syringe

2 ML Dupixent 150 MG/ML Prefilled Syringe


lidocaine hydrochloride 30 MG/ML [CidalEaze]


zinc pyrithione 0.5 % Medicated Liquid Soap

zinc pyrithione 5 MG/ML Medicated Liquid Soap


benzalkonium chloride 2.6 MG/ML Topical Solution


haloperidol 5 MG in 1 ML Prefilled Syringe

haloperidol 5 MG per 1 ML Prefilled Syringe

1 ML haloperidol 5 MG/ML Prefilled Syringe


benzalkonium chloride 0.26 % Medicated Liquid Soap

benzalkonium chloride 2.6 MG/ML Medicated Liquid Soap


naldemedine 0.2 MG Oral Tablet [Symproic]


benzocaine / menthol / zinc chloride Topical Product


benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG [Aktipak]


benzoyl peroxide / erythromycin Topical Gel [Aktipak]


benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel [Aktipak]


immunoglobulin G, human 100 MG/ML [Gammaplex]


50 ML Gammaplex 100 MG/ML Injection
Gammaplex 10 % per 50 ML Injection
Gammaplex 10 % in 50 ML Injection

50 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex]


100 ML Gammaplex 100 MG/ML Injection
Gammaplex 10 % per 100 ML Injection
Gammaplex 10 % in 100 ML Injection

100 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex]


Gammaplex 10 % in 200 ML Injection
Gammaplex 10 % per 200 ML Injection
200 ML Gammaplex 100 MG/ML Injection

200 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex]


yellow fever virus strain 17D-204 live antigen 2000 UNT/ML


yellow fever vaccine (generic for Stamaril) 0.5 ML Injection

0.5 ML yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection


yellow fever virus strain 17D-204 live antigen 2000 UNT/ML [Stamaril]


yellow fever virus strain 17D-204 live antigen Injection [Stamaril]


STAMARIL 0.5 ML Injection
0.5 ML Stamaril 2000 UNT/ML Injection

0.5 ML yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection [Stamaril]


{1 (35000 MG) (lanolin 15.5 % / petrolatum 53.4 % Topical Ointment)/ 1 (35000 MG) (lidocaine 4 % Topical Cream Topical Cream) } Pack

{1 (1.25 OZ) (lanolin 15.5 % / petrolatum 53.4 % Topical Ointment)/ 1 (1.25 OZ) (lidocaine 4 % Topical Cream Topical Cream) } Pack

{1 (35000 MG) (lanolin 0.155 MG/MG / petrolatum 0.534 MG/MG Topical Ointment) / 1 (35000 MG) (lidocaine 40 MG/ML Topical Cream) } Pack


{21 (desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 5 (ethinyl estradiol 0.01 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Simliya 28 Day]


deutetrabenazine 12 MG Oral Tablet [Austedo]


deutetrabenazine 6 MG Oral Tablet [Austedo]


deutetrabenazine 9 MG Oral Tablet [Austedo]


abiraterone acetate 500 MG Oral Tablet [Zytiga]


adalimumab starter pack 80 MG/0.8 mL and 40 MG/0.4 mL Auto-Injector (3 count)

adalimumab starter pack 80 MG/0.8 ML and 40 MG/0.4 ML Auto-Injector (3 count)

{2 (0.4 ML adalimumab 100 MG/ML Auto-Injector) / 1 (0.8 ML adalimumab 100 MG/ML Auto-Injector) } Pack


A small molecule and androgen receptor (AR) antagonist with potential antineoplastic activity. Apalutamide binds to AR in target tissues thereby preventing androgen-induced receptor activation and facilitating the formation of inactive complexes that cannot be translocated to the nucleus. This prevents binding to and transcription of AR-responsive genes. This ultimately inhibits the expression of genes that regulate prostate cancer cell proliferation and may lead to an inhibition of cell growth in AR-expressing tumor cells.


A humanized IgG1 monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. Isatuximab specifically binds to CD38 on CD38-positive tumor cells. This may trigger antitumoral antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC) and apoptosis eventually leading to cell lysis in CD38-expressing tumor cells. CD38, a type II transmembrane glycoprotein, is present on various immune cells and hematologic malignancies, and its expression has been correlated with poor prognosis.


An orally bioavailable inhibitor of both steroid 11beta-hydroxylase (cytochrome P450 (CYP) 11B1) and aldosterone synthase (CYP11B2; steroid 18-hydroxylase), with potential anti-adrenal activity and ability to treat Cushing disease (CD). Upon administration, osilodrostat binds to and inhibits the activity of CYP11B1, the enzyme that catalyzes the final step of cortisol synthesis from the precursor 11-deoxycortisol, and CYP11B2, the enzyme that catalyzes aldosterone synthesis from corticosterone and 11-deoxycorticosterone in the adrenal gland. The inhibition of CYP11B1 prevents the production of excess cortisol, thereby decreasing and normalizing the levels of cortisol. CD is most often caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor.


fluticasone / salmeterol Dry Powder Inhaler [AirDuo]


AirDuo RespiClick 113/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations

AirDuo RespiClick 113/14 Dry Powder Inhaler, 60 ACTUAT

AirDuo 113/14 (fluticasone propionate 113 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT

60 ACTUAT fluticasone propionate 0.113 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]


AirDuo RespiClick 232/14 Dry Powder Inhaler, 60 ACTUAT

AirDuo RespiClick 232/14 MCG/INHAL Dry Powder Inhaler, 60 Actuations

AirDuo 232/14 (fluticasone propionate 232 MCG / salmeterol 14 MCG (equivalent to salmeterol xinafoate 20.3 MCG)) per ACTUAT Dry Powder Inhaler, 60 ACTUAT

60 ACTUAT fluticasone propionate 0.232 MG/ACTUAT / salmeterol 0.014 MG/ACTUAT Dry Powder Inhaler [AirDuo]


pseudoephedrine Oral Capsule [Zephrex-D]


pseudoephedrine hydrochloride 30 MG Oral Capsule [Zephrex-D]


valbenazine 40 MG (as valbenazine tosylate 73 MG) Oral Capsule


Ingrezza 40 MG (as valbenazine tosylate 73 MG) Oral Capsule

valbenazine 40 MG Oral Capsule [Ingrezza]


acrylate/isobutyl methacrylate/N-tert-octylacrylamide copolymer (75000 MW)


low-substituted hydroxypropyl cellulose (11% hydroxypropyl; 120000 MW)


inFLIXimab-abda 100 MG Injection [Renflexis]

infliximab-abda 100 MG Injection [Renflexis]


diphenhydrAMINE hydrochloride 25 MG [Dormin]

diphenhydramine hydrochloride 25 MG [Dormin]


diphenhydrAMINE hydrochloride 25 MG Oral Capsule [Dormin]

diphenhydramine hydrochloride 25 MG Oral Capsule [Dormin]


acetaminophen 650 MG / dextromethorphan HBr 20 MG per 20 mL Oral Solution

APAP 32.5 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Solution

acetaminophen 325 MG / dextromethorphan HBr 10 MG per 10 mL Oral Solution

acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution

acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Solution


cholecalciferol / glucose Oral Gel Product


carprofen 100 MG Chewable Tablet [Caprieve]


durvalumab 120 in 2.4 ML Injection
durvalumab 120 per 2.4 ML Injection


2.4 ML Imfinzi 50 MG/ML Injection
IMFINZI 120 MG in 2.4 ML Injection
IMFINZI 120 MG per 2.4 ML Injection

2.4 ML durvalumab 50 MG/ML Injection [Imfinzi]


durvalumab 500 MG per 10 ML Injection
durvalumab 500 MG in 10 ML Injection


IMFINZI 500 MG per 10 ML Injection
IMFINZI 500 MG in 10 ML Injection
10 ML Imfinzi 50 MG/ML Injection

10 ML durvalumab 50 MG/ML Injection [Imfinzi]


carprofen 100 MG Chewable Tablet [Novox]


carprofen 100 MG Chewable Tablet [OstiFen]


carprofen 25 MG Chewable Tablet [Caprieve]


carprofen 25 MG Chewable Tablet [OstiFen]


carprofen 75 MG Chewable Tablet [Caprieve]


carprofen 75 MG Chewable Tablet [OstiFen]


ascorbic acid / iron carbonyl Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]


adalimumab 10 MG in 0.1 ML Prefilled Syringe

0.1 ML adalimumab 100 MG/ML Prefilled Syringe

adalimumab 10 MG per 0.1 ML Prefilled Syringe


adalimumab 20 MG per 0.2 ML Prefilled Syringe

adalimumab 20 MG in 0.2 ML Prefilled Syringe

0.2 ML adalimumab 100 MG/ML Prefilled Syringe


0.2 ML Humira 100 MG/ML Prefilled Syringe

Humira 20 MG in 0.2 ML Prefilled Syringe

0.2 ML adalimumab 100 MG/ML Prefilled Syringe [Humira]

Humira 20 MG per 0.2 ML Prefilled Syringe


abaloparatide 3120 MCG per 1.56 ML Pen Injector

abaloparatide 3120 MCG in 1.56 ML Pen Injector

abaloparatide 2000 MCG/ML per 1.56 ML Pen Injector

abaloparatide 80 MCG per 0.04 ML Pen Injector

1.56 ML abaloparatide 2 MG/ML Pen Injector


Tymlos 2000 MCG/ML per 1.56 ML Pen Injector

Tymlos 3120 MCG per 1.56 ML Pen Injector

1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos]


capsaicin 0.002 % / menthol 10 % / methyl salicylate 20 % Topical Cream

capsaicin 0.02 MG/ML / menthol 100 MG/ML / methyl salicylate 200 MG/ML Topical Cream


carprofen 100 MG Chewable Tablet [Levafen]


carprofen 25 MG Chewable Tablet [Levafen]


carprofen 75 MG Chewable Tablet [Levafen]


Alunbrig 30 MG Oral Tablet
ALUNBRIG 30 MG Oral Tablet


adalimumab 80 MG per 0.8 ML Auto-Injector

adalimumab 80 MG in 0.8 mL Auto-Injector

0.8 ML adalimumab 100 MG/ML Auto-Injector


0.8 ML adalimumab 100 MG/ML Auto-Injector [Humira]


rucaparib (as rucaparib camisylate) 250 MG Oral Tablet


Rubraca (as rucaparib camisylate) 250 MG Oral Tablet


methotrexate 2.5 MG/ML (methotrexate sodium 2.74 MG/ML) Oral Solution


methotrexate 2.5 MG/ML (methotrexate sodium 2.74 MG/ML) Oral Solution [Xatmep]

methotrexate 2.5 MG/ML Oral Solution [Xatmep]


MiconaHex+Triz (chlorhexidine gluconate 2 % / miconazole nitrate 2 % ) Medicated Shampoo

MiconaHex+Triz 2 % / 2 % Medicated Shampoo

chlorhexidine gluconate 20 MG/ML / miconazole nitrate 20 MG/ML Medicated Shampoo [MiconaHex+Triz]


Brassica oleracea var. botrytis whole extract


100 ML Radicava 0.3 MG/ML Injection
Radicava 30 MG per 100 ML Injection
Radicava 30 MG in 100 ML Injection

100 ML edaravone 0.3 MG/ML Injection [Radicava]


camphor 3.1 % / menthol 1.3 % Topical Cream

camphor 31 MG/ML / menthol 13 MG/ML Topical Cream


human vaccinia immune globulin 2500 UNT/ML


human vaccinia immune globulin Injection


Human vaccinia immune globulin 50,000 UNT per 20 ML Injection

Human vaccinia immune globulin 50,000 UNT in 20 ML Injection

20 ML human vaccinia immune globulin 2500 UNT/ML Injection


human vaccinia immune globulin 2500 UNT/ML [CNJ-016]


human vaccinia immune globulin Injection [CNJ-016]


20 ML CNJ-016 2500 UNT/ML Injection
CNJ-016 50,000 UNT in 20 ML Injection
CNJ-016 50,000 UNT per 20 ML Injection

20 ML human vaccinia immune globulin 2500 UNT/ML Injection [CNJ-016]


cerliponase alfa 150 MG per 5 ML Intraventricular Injection

cerliponase alfa 150 MG in 5 mL Intraventricular Injection

5 ML cerliponase alfa 30 MG/ML Injection


Brineura 150 MG per 5 ML Intraventricular Injection

Brineura 150 MG in 5 mL Intraventricular Injection

5 ML cerliponase alfa 30 MG/ML Injection [Brineura]


Xadago 100 MG (as safinamide mesylate 131.76 MG) Oral Tablet


trastuzumab 150 MG Injection [Herceptin]


trastuzumab 21 MG/ML Injectable Solution


diphenhydrAMINE hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG [Wal-Dryl-D Allergy]

diphenhydramine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG [Wal-Dryl-D Allergy]


diphenhydrAMINE / pseudoephedrine Oral Tablet [Wal-Dryl-D Allergy]

diphenhydramine / pseudoephedrine Oral Tablet [Wal-Dryl-D Allergy]


diphenhydrAMINE hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Wal-Dryl-D Allergy]

Wal-Dryl-D Allergy & Sinus 25 MG / 60 MG Oral Tablet

diphenhydramine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Wal-Dryl-D Allergy]


My Choice Emergency Contraceptive 1.5 MG Oral Tablet

levonorgestrel 1.5 MG Oral Tablet [My Choice]


Ambrosia artemisiifolia pollen extract 100 UNT/ML / Ambrosia trifida pollen extract 100 UNT/ML Injectable Solution

Ambrosia artemisiifolia pollen extract 100 PNU/ML / Ambrosia trifida pollen extract 100 PNU/ML Injectable Solution

giant ragweed pollen extract 100 UNT/ML / short ragweed pollen extract 100 UNT/ML Injectable Solution


Ambrosia artemisiifolia pollen extract 20000 UNT/ML / Ambrosia trifida pollen extract 20000 UNT/ML Injectable Solution

Ambrosia artemisiifolia pollen extract 20000 PNU/ML / Ambrosia trifida pollen extract 20000 PNU/ML Injectable Solution

giant ragweed pollen extract 20000 UNT/ML / short ragweed pollen extract 20000 UNT/ML Injectable Solution


Ambrosia artemisiifolia pollen extract 40000 PNU/ML / Ambrosia trifida pollen extract 40000 PNU/ML Injectable Solution

Ambrosia artemisiifolia pollen extract 40000 UNT/ML / Ambrosia trifida pollen extract 40000 UNT/ML Injectable Solution

giant ragweed pollen extract 40000 UNT/ML / short ragweed pollen extract 40000 UNT/ML Injectable Solution


shagbark hickory pollen extract 100 UNT/ML


pecan pollen extract / shagbark hickory pollen extract Injectable Product


pecan pollen extract / shagbark hickory pollen extract Injectable Solution


pecan pollen extract / shagbark hickory pollen extract


Carya illinoinensis pollen UNT/ML / Carya ovata pollen extract 100 UNT/ML Injectable Solution

pecan pollen extract 100 UNT/ML / shagbark hickory pollen extract 100 UNT/ML Injectable Solution


acetyl trifluoromethylphenyl valylglycine, DL-


camphor 0.1 MG/MG / menthol 0.14 MG/MG Topical Gel


levothyroxine sodium 175 MCG Oral Capsule

levothyroxine sodium 0.175 MG Oral Capsule


levothyroxine sodium 0.175 MG [Tirosint]


Tirosint 0.175 MG Oral Capsule
Tirosint 175 MCG Oral Capsule

levothyroxine sodium 0.175 MG Oral Capsule [Tirosint]


levothyroxine sodium 200 MCG Oral Capsule

levothyroxine sodium 0.2 MG Oral Capsule


Tirosint 0.2 MG Oral Capsule
Tirosint 200 MCG Oral Capsule

levothyroxine sodium 0.2 MG Oral Capsule [Tirosint]


camphor 0.003 MG/MG / menthol 0.003 MG/MG [Rhuli]


Rhuli (camphor 0.3 % / Menthol 0.3 % ) Topical Gel

camphor 0.003 MG/MG / menthol 0.003 MG/MG Topical Gel [Rhuli]


menthol 0.019 MG/MG / methyl salicylate 0.137 MG/MG [Cramergesic]


menthol / methyl salicylate Topical Ointment [Cramergesic]


Chamaecyparis lawsoniana fruiting twig extract


NOLIX 0.05 % Topical Lotion
Nolix 0.5 MG/ML Topical Lotion
Nolix 0.05 % Topical Lotion

flurandrenolide 0.5 MG/ML Topical Lotion [Nolix]


capsaicin / methyl salicylate Topical Ointment


capsaicin 0.025 % / methyl salicylate 12.5 % Topical Ointment

capsaicin 0.00025 MG/MG / methyl salicylate 0.125 MG/MG Topical Ointment


sarilumab 150 MG in 1.14 mL Prefilled Syringe

sarilumab 150 MG per 1.14 ML Prefilled Syringe

1.14 ML sarilumab 132 MG/ML Prefilled Syringe


1.14 ML Kevzara 132 MG/ML Prefilled Syringe

KEVZARA 150 MG in 1.14 mL Prefilled Syringe

Kevzara 150 MG per 1.14 ML Prefilled Syringe

1.14 ML sarilumab 132 MG/ML Prefilled Syringe [Kevzara]


dimethicone / petrolatum Topical Ointment


dimethicone 1.5 % / petrolatum 85 % Topical Ointment

dimethicone 0.015 MG/MG / petrolatum 0.85 MG/MG Topical Ointment


sarilumab 200 MG per 1.14 ML Prefilled Syringe

sarilumab 200 MG in 1.14 mL Prefilled Syringe

1.14 ML sarilumab 175 MG/ML Prefilled Syringe


Kevzara 200 MG per 1.14 ML Prefilled Syringe

1.14 ML Kevzara 175 MG/ML Prefilled Syringe

KEVZARA 200 MG in 1.14 mL Prefilled Syringe

1.14 ML sarilumab 175 MG/ML Prefilled Syringe [Kevzara]


sodium monofluorophosphate 0.86 % Toothpaste

sodium monofluorophosphate 0.86 % (fluoride ion 0.15 % ) Toothpaste

sodium monofluorophosphate 0.0086 MG/MG Toothpaste


phytonadione (vit K 1) 0.5 MG Sublingual Tablet


Lactobacillus rhamnosus GG 2,000,000,000 UNT per 0.4 ML Oral Suspension

Lactobacillus rhamnosus GG 2,000,000,000 UNT in 0.4 mL Oral Suspension

Lacticaseibacillus rhamnosus GG 5000000000 UNT/ML Oral Suspension


dextromethorphan / pyrilamine Oral Tablet


dextromethorphan HBr 30 MG / pyrilamine maleate 30 MG Oral Tablet

dextromethorphan hydrobromide 30 MG / pyrilamine maleate 30 MG Oral Tablet


CLAVAMOX 100 MG / 25 MG Chewable Tablet
Clavamox 100 MG / 25 MG Chewable Tablet

amoxicillin 100 MG / clavulanate 25 MG Chewable Tablet [Clavamox]


CLAVAMOX 200 MG / 50 MG Chewable Tablet
Clavamox 200 MG / 50 MG Chewable Tablet

amoxicillin 200 MG / clavulanate 50 MG Chewable Tablet [Clavamox]


Clavamox 300 MG / 75 MG Chewable Tablet
CLAVAMOX 300 MG / 75 MG Chewable Tablet

amoxicillin 300 MG / clavulanate 75 MG Chewable Tablet [Clavamox]


CLAVAMOX 50 MG / 12.5 MG Chewable Tablet

Clavamox 50 MG / 12.5 MG Chewable Tablet

amoxicillin 50 MG / clavulanate 12.5 MG Chewable Tablet [Clavamox]


benzocaine 15 MG / menthol 20 MG Oral Lozenge


benzocaine 15 MG / menthol 20 MG [Cepacol Sore Throat Pain Relief]


Cepacol Sore Throat Pain Relief (benzocaine 15 MG / menthol 20 MG) Oral Lozenge

Cepacol Instamax Sore Throat Pain Relief 15 MG / 20 MG Oral Lozenge

benzocaine 15 MG / menthol 20 MG Oral Lozenge [Cepacol Sore Throat Pain Relief]


Angelica dahurica var. formosana root extract


boric acid (H3BO3), cmpd. with 2,2',2''-nitrilotris(ethanol) (1:3)


Dichapetalum madagascariense bark/leaf extract


menthol 25 MG/ML / methyl salicylate 100 MG/ML [Oxyrub Max]


menthol / methyl salicylate Topical Cream [Oxyrub Max]


Oxyrub Max 25 MG/ML / 100 MG/ML Topical Cream

menthol 25 MG/ML / methyl salicylate 100 MG/ML Topical Cream [Oxyrub Max]


NP Thyroid (levothyroxine sodium 76 MCG / liothyronine sodium 18 MCG) Oral Tablet

thyroid (USP) 120 MG Oral Tablet [NP Thyroid]


Jadenu Sprinkle 90 MG Oral Granules
Jadenu 90 MG Oral Granules

deferasirox 90 MG Oral Granules [Jadenu]


Jadenu 360 MG Oral Granules
Jadenu Sprinkle 360 MG Oral Granules

deferasirox 360 MG Oral Granules [Jadenu]


Jadenu Sprinkle 180 MG Oral Granules
Jadenu 180 MG Oral Granules

deferasirox 180 MG Oral Granules [Jadenu]


minolira 105 MG 24HR Extended Release Oral Tablet

Minolira 105 MG 24 HR Extended Release Oral Tablet

Minolira 105 MG (26.25 MG Immediate Release Beads / 78.75 MG Extended Release Beads) 24 HR Extended Release Oral Tablet

Minolira 105 MG (as minocycline HCl 113.4 MG) 24 HR Extended Release Oral Tablet

24 HR minocycline 105 MG Extended Release Oral Tablet [Minolira]


raltegravir 600 MG (as raltegravir potassium 651.6 MG) Oral Tablet


Isentress 600 MG (as raltegravir potassium 651.6 MG) Oral Tablet

raltegravir 600 MG Oral Tablet [Isentress]


edaravone 30 MG in 100 ML Injection
edaravone 30 MG per 100 ML Injection


hydrocortisone Topical Cream [Hydroskin]


abatacept 50 MG in 0.4 ML Prefilled Syringe

abatacept 50 MG per 0.4 ML Prefilled Syringe

0.4 ML abatacept 125 MG/ML Prefilled Syringe


Orencia 50 MG per 0.4 ML Prefilled Syringe

Orencia 50 MG in 0.4 ML Prefilled Syringe

0.4 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]


abatacept 87.5 MG per 0.7 ML Prefilled Syringe

abatacept 87.5 MG in 0.7 ML Prefilled Syringe

0.7 ML abatacept 125 MG/ML Prefilled Syringe


Orencia 87.5 MG per 0.7 ML Prefilled Syringe

0.7 ML Orencia 125 MG/ML Prefilled Syringe

Orencia 87.5 MG in 0.7 ML Prefilled Syringe

0.7 ML abatacept 125 MG/ML Prefilled Syringe [Orencia]


3.9 ML ARIPiprazole lauroxil 273 MG/ML Prefilled Syringe

ARIPiprazole lauroxil 1064 MG in 3.9 ML Prefilled Syringe

ARIPiprazole lauroxil 1064 MG per 3.9 ML Prefilled Syringe

aripiprazole lauroxil 1064 MG per 3.9 ML Prefilled Syringe

3.9 ML aripiprazole lauroxil 273 MG/ML Prefilled Syringe


ARIPiprazole lauroxil 273 MG/ML [Aristada]

aripiprazole lauroxil 273 MG/ML [Aristada]


3.9 ML ARIPiprazole lauroxil 273 MG/ML Prefilled Syringe [Aristada]

Aristada 1064 MG per 3.9 ML Prefilled Syringe

3.9 ML Aristada 273 MG/ML Prefilled Syringe

Aristada 1064 MG in 3.9 ML Prefilled Syringe

3.9 ML aripiprazole lauroxil 273 MG/ML Prefilled Syringe [Aristada]


Sydney golden wattle pollen extract 10000 UNT/ML


dapagliflozin / sAXagliptin Oral Product

dapagliflozin / saxagliptin Oral Product


dapagliflozin 10 MG / sAXagliptin 5 MG [Qtern]

dapagliflozin 10 MG / saxagliptin 5 MG [Qtern]


dapagliflozin / sAXagliptin Oral Tablet [Qtern]

dapagliflozin / saxagliptin Oral Tablet [Qtern]


APAP 325 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG Oral Tablet

acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG Oral Tablet

acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG Oral Tablet


cetirizine 2.4 MG (as cetirizine HCl 2.85 MG) per 1 ML Ophthalmic Solution

cetirizine 2.4 MG/ML Ophthalmic Solution


aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1700 MG [Alka-Seltzer]


riboflavin 5'-phosphate Ophthalmic Product


riboflavin 5'-phosphate Ophthalmic Solution


riboflavin 5'-phosphate 1.46 MG/ML [Photrexa]


riboflavin 5'-phosphate Ophthalmic Solution [Photrexa]


salicylic acid Medicated Liquid Soap [Clearasil Daily Clear]


Clearasil Daily Clear 20 MG/ML Medicated Liquid Soap

Clearasil Daily Clear 2 % Medicated Liquid Soap

salicylic acid 20 MG/ML Medicated Liquid Soap [Clearasil Daily Clear]


menthol 0.8 % / witch hazel 10 % Topical Cream

menthol 8 MG/ML / witch hazel 100 MG/ML Topical Cream


calcium chloride / sodium fluoride / sodium phosphate, monobasic


European house dust mite allergenic extract Injectable Product


European house dust mite allergenic extract Injectable Solution


European house dust mite allergenic extract 30000 AU/ML


American house dust mite allergenic extract Injectable Product


American house dust mite allergenic extract Injectable Solution


diphenhydrAMINE hydrochloride 25 MG / phenylephrine hydrochloride 10 MG [Benadryl Allergy Plus Congestion]

diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG [Benadryl Allergy Plus Congestion]


diphenhydrAMINE / phenylephrine Oral Tablet [Benadryl Allergy Plus Congestion]

diphenhydramine / phenylephrine Oral Tablet [Benadryl Allergy Plus Congestion]


Benadryl Allergy Plus Congestion Oral Product


Benadryl Allergy Plus Congestion (diphenhydrAMINE HCl 25 MG / phenylephrine HCl 10 MG) Oral Tablet

diphenhydrAMINE hydrochloride 25 MG / phenylephrine hydrochloride 10 MG Oral Tablet [Benadryl Allergy Plus Congestion]

Benadryl Allergy Plus Congestion 25 MG / 10 MG Oral Tablet

Benadryl Allergy Plus Congestion (diphenhydramine HCl 25 MG / phenylephrine HCl 10 MG) Oral Tablet

diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 10 MG Oral Tablet [Benadryl Allergy Plus Congestion]


American house dust mite allergenic extract 30000 AU/ML


insulin lispro 100 UNT/ML in 3 ML Pen Injector, 0.5 UNT Doses

insulin lispro 100 UNT/ML per 3 ML Pen Injector, 0.5 UNT Doses

0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector


Humalog Junior KwikPen 100 UNT/ML per 3 ML Pen Injector

0.5 UNT Doses 3 ML Humalog 100 UNT/ML Pen Injector

HumaLOG Junior 100 UNT/ML in 3 ML Pen Injector

0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector [HumaLOG]

HumaLOG Junior KwikPen 100 UNT/ML per 3 ML Pen Injector

0.5 UNT Doses 3 ML HumaLOG 100 UNT/ML Pen Injector

0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector [Humalog]


benzalkonium chloride 0.1 % Medicated Bar Soap

benzalkonium chloride 0.001 MG/MG Medicated Bar Soap


Oryctolagus cuniculus pancreatin preparation


tetracycline hydrochloride 0.03 MG/MG [Viabecline]


tetracycline Topical Ointment [Viabecline]


Viabecline 0.03 MG/MG Topical Ointment
Viabecline 3 % Topical Ointment
VIABECLINE 3 % Topical Ointment

tetracycline hydrochloride 0.03 MG/MG Topical Ointment [Viabecline]


benzyl alcohol 10 % / lidocaine HCl 4 % Topical Cream

benzyl alcohol 0.1 ML/ML / lidocaine hydrochloride 40 MG/ML Topical Cream


magnesium sulfate / potassium chloride / potassium phosphate / sodium chloride / sodium phosphate Irrigation Product


hydrocortisone 10 MG/ML Medicated Shampoo


ascorbic acid / iron carbonyl Chewable Product


ascorbic acid / iron carbonyl Chewable Tablet


iron carbonyl 60 MG / vitamin C 250 MG Chewable Tablet

vitamin C 250 MG / Iron Carbonyl 60 MG Chewable Tablet

vit-C 250 MG / Iron Carbonyl 60 MG Chewable Tablet

ascorbic acid 250 MG / iron carbonyl 60 MG Chewable Tablet


C1 esterase inhibitor (human) 2000 UNT Injection


C1 esterase inhibitor (human) 2000 UNT [Haegarda]


C1 esterase inhibitor Injection [Haegarda]


C1 esterase inhibitor (human) 3000 UNT Injection


C1 esterase inhibitor (human) 3000 UNT [Haegarda]


methylphenidate Disintegrating Oral Product


methylphenidate Disintegrating Oral Tablet


methylphenidate 17.3 MG Extended Release Disintegrating Oral Tablet

methylphenidate 17.3 MG Disintegrating Oral Tablet


methylphenidate Disintegrating Oral Tablet [Cotempla]


Cotempla XR-ODT 17.3 MG Extended Release Disintegrating Oral Tablet

Cotempla 17.3 MG Disintegrating Oral Tablet

methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]


methylphenidate 25.9 MG Extended Release Disintegrating Oral Tablet

methylphenidate 25.9 MG Disintegrating Oral Tablet


Cotempla 25.9 MG Disintegrating Oral Tablet

Cotempla XR-ODT 25.9 MG Extended Release Disintegrating Oral Tablet

methylphenidate 25.9 MG Disintegrating Oral Tablet [Cotempla]


methylphenidate 8.6 MG Extended Release Disintegrating Oral Tablet

methylphenidate 8.6 MG Disintegrating Oral Tablet


Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet

Cotempla 8.6 MG Disintegrating Oral Tablet

methylphenidate 8.6 MG Disintegrating Oral Tablet [Cotempla]


triprolidine HCl 1.25 MG per 1 mL Oral Solution

triprolidine HCl 1.25 MG in 1 mL Oral Solution

triprolidine hydrochloride 1.25 MG/ML Oral Solution


allantoin 1.5 % / dimethicone 2 % Topical Cream

allantoin 15 MG/ML / dimethicone 20 MG/ML Topical Cream


benzalkonium chloride 0.3 % Topical Spray

benzalkonium chloride 3 MG/ML Topical Spray


0.3 ML EPINEPHrine 1 MG/ML Prefilled Syringe [Symjepi]

Symjepi 0.3 MG per 0.3 ML Prefilled Syringe

SYMJEPI 0.3 MG in 0.3 mL Prefilled Syringe

0.3 ML Symjepi 1 MG/ML Prefilled Syringe

0.3 ML epinephrine 1 MG/ML Prefilled Syringe [Symjepi]


inulin 5 GM / vitamin D3 1000 UNT Chewable Tablet

cholecalciferol 1000 UNT / inulin 5000 MG Chewable Tablet

cholecalciferol 0.025 MG / inulin 5000 MG Chewable Tablet


camphor 0.03 MG/MG / menthol 0.03 MG/MG [Healqu]


HealQu (camphor 3 % / menthol 3 % ) Topical Gel

HEALQU warm therapy 3 % / 3 % Topical Gel

camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel [Healqu]


amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG 3-Bead 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG Extended Release Oral Capsule


amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG [Mydayis]


amphetamine / dextroamphetamine Extended Release Oral Capsule [Mydayis]


Mydayis 50 MG 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 12.5 MG / amphetamine sulfate 12.5 MG / dextroamphetamine saccharate 12.5 MG / dextroamphetamine sulfate 12.5 MG Extended Release Oral Capsule [Mydayis]


amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG 3-Bead 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG Extended Release Oral Capsule


amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG [Mydayis]


Mydayis 25 MG 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 6.25 MG / amphetamine sulfate 6.25 MG / dextroamphetamine saccharate 6.25 MG / dextroamphetamine sulfate 6.25 MG Extended Release Oral Capsule [Mydayis]


box elder maple pollen extract / red maple pollen extract Injectable Product


box elder maple pollen extract / red maple pollen extract Injectable Solution


box elder maple pollen extract / red maple pollen extract


box elder maple pollen extract 50 MG/ML / red maple pollen extract 50 MG/ML Injectable Solution

Acer negundo pollen extract 50 MG/ML / Acer rubrum pollen extract 50 MG/ML Injectable Solution

Acer negundo pollen extract 0.05 GM/ML / Acer rubrum pollen extract 0.05 GM/ML Injectable Solution


amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG 3-Bead 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG Extended Release Oral Capsule


amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG [Mydayis]


Mydayis 12.5 MG 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG Extended Release Oral Capsule [Mydayis]


amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG 3-Bead 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG Extended Release Oral Capsule


amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG [Mydayis]


Mydayis 37.5 MG 24HR Extended Release Oral Capsule

3-Bead 24 HR amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG Extended Release Oral Capsule [Mydayis]


gray birch pollen extract / river birch pollen extract Injectable Product


gray birch pollen extract / river birch pollen extract Injectable Solution


gray birch pollen extract / river birch pollen extract


gray birch pollen extract 50 MG/ML / river birch pollen extract 50 MG/ML Injectable Solution

Betula nigra pollen extract 50 MG/ML / Betula populifolia pollen extract 50 MG/ML Injectable Solution

Betula nigra pollen extract 0.05 GM/ML / Betula populifolia pollen extract 0.05 GM/ML Injectable Solution


delafloxacin 300 MG (as delafloxacin meglumine 433 MG) Injection


Baxdela 300 MG (as delafloxacin meglumine 433 MG) Injection


delafloxacin 450 MG (as delafloxacin meglumine 649 MG) Oral Tablet


Baxdela 450 MG (as delafloxacin meglumine 649 MG) Oral Tablet

delafloxacin 450 MG Oral Tablet [Baxdela]


Carya illinoinensis pollen 50 MG/ML / Carya ovata pollen extract 50 MG/ML Injectable Solution

pecan pollen extract 50 MG/ML / shagbark hickory pollen extract 50 MG/ML Injectable Solution

Carya illinoinensis pollen 0.05 GM/ML / Carya ovata pollen extract 0.05 GM/ML Injectable Solution


Q-Sorb Co Q-10 (ubidecarenone) 200 MG Oral Capsule

ubidecarenone 200 MG Oral Capsule [Q-Sorb Co Q-10]


Q-Sorb Co Q-10 (ubidecarenone) 400 MG Oral Capsule

ubidecarenone 400 MG Oral Capsule [Q-Sorb Co Q-10]


betrixaban 40 MG (as betrixiban maleate) Oral Capsule


Bevyxxa 40 MG (as betrixaban maleate 50.28 MG) Oral Capsule


betrixaban 80 MG (as betrixiban maleate) Oral Capsule


Bevyxxa 80 MG (as betrixiban maleate 100.56 MG) Oral Capsule


Parasitexx 144 MG in 1 mL Oral Suspension

Parasitexx 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension

pyrantel pamoate 144 MG/ML Oral Suspension [Parasitexx]


hyaluronidase, human recombinant 2000 UNT/ML


hyaluronidase / riTUXimab Injectable Product

hyaluronidase / rituximab Injectable Product


A combination preparation of rituximab, a genetically engineered chimeric murine/human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against the CD20 antigen, and the recombinant form of the human enzyme hyaluronidase, with antineoplastic activity. Upon subcutaneous administration of rituximab and hyaluronidase human, the hyaluronidase reversibly depolymerizes the polysaccharide hyaluronan in the subcutaneous tissue. This increases the permeability of the subcutaneous tissue and enhances the absorption of rituximab into the systemic circulation. In turn, rituximab targets and binds to CD20 expressed on tumor cells, and induces tumor cell lysis primarily through the induction of complement dependent cytotoxicity (CDC) and antibody-dependent cell mediated cytotoxicity (ADCC). When administered subcutaneously, hyaluronidase, an endoglycosidase, increases the dispersion and absorption of co-administered drugs. CD20 is expressed on the surface of pre-B and mature B-lymphocytes, and is overexpressed in a variety of B-cell malignancies.


rituximab 1400 MG / hyaluronidase, human recombinant 23,400 UNT per 11.7 ML Injection

11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML Injection

riTUXimab 1400 MG / hyaluronidase, human recombinant 23,400 UNT in 11.7 ML Injection

riTUXimab 1400 MG / hyaluronidase, human recombinant 23,400 UNT per 11.7 ML Injection

11.7 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection


hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML [Rituxan Hycela]

hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML [Rituxan Hycela]


hyaluronidase / riTUXimab Injection [Rituxan Hycela]

hyaluronidase / rituximab Injection [Rituxan Hycela]


13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML Injection

rituximab 1600 MG / hyaluronidase, human recombinant 26,800 UNT per 13.4 ML Injection

riTUXimab 1600 MG / hyaluronidase, human recombinant 26,800 UNT in 13.4 mL Injection

riTUXimab 1600 MG / hyaluronidase, human recombinant 26,800 UNT per 13.4 ML Injection

13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection


camphor 0.06 MG/MG / menthol 0.07 MG/MG Topical Gel


dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG per 15 ML Oral Solution

dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 15 ML Oral Solution

dextromethorphan hydrobromide 0.67 MG/ML / phenylephrine hydrochloride 0.33 MG/ML Oral Solution


Butatron 1 GM Oral Tablet
Butatron 1000 MG Oral Tablet

phenylbutazone 1000 MG Oral Tablet [Butatron]


influenza A virus A/Michigan/45/2015 (H1N1) antigen


influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen


influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza A virus A/Michigan/45/2015 (H1N1) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


tocopherol acetate 6 UNT / ubidecarenone 30 MG [Q-Gel]


influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen


influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen / influenza B virus B/Hong Kong/259/2010 antigen / influenza B virus B/Utah/9/2014 antigen


dibasic potassium phosphate / potassium phosphate Injection


5 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection

5 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection

5 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection

potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) in 5 ML Injection

phosphorus 15 MMOL / potassium 22 MEQ per 5 ML Injection

potassium phosphates (phosphorus 15 MMOL / potassium 22 MEQ) per 5 ML Injection


50 ML dibasic potassium phosphate 236 MG/ML / monobasic potassium phosphate 224 MG/ML Injection

potassium phosphates (phosphorus 150 MMOL / potassium 220 MEQ) per 50 ML Injection

50 ML Dibasic Pot phosphate 236 MG/ML / Monobasic Pot phosphate 224 MG/ML Injection

50 ML Dibasic K+ phosphate 236 MG/ML / Monobasic K+ phosphate 224 MG/ML Injection

phosphorus 150 MMOL / potassium 220 MEQ per 50 ML Injection

potassium phosphates (phosphorus 150 MMOL / potassium 220 MEQ) in 50 ML Injection


allantoin / dimethicone / menthol Topical Cream


guselkumab 100 MG in 1 ML Prefilled Syringe

1 ML guselkumab 100 MG/ML Prefilled Syringe


Tremfya 100 MG in 1 ML Prefilled Syringe

1 ML Tremfya 100 MG/ML Prefilled Syringe

1 ML guselkumab 100 MG/ML Prefilled Syringe [Tremfya]


allantoin 0.5 % / dimethicone 2 % / menthol 0.45 % Topical Cream

allantoin 5 MG/ML / dimethicone 20 MG/ML / menthol 4.5 MG/ML Topical Cream


1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.009 MG/ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 0.009 MG per 1.7 ML Cartridge

articaine hydrochloride 40 MG / epinephrine bitartrate 0.009 MG per 1.7 ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 1:200,000 in 1.7 ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 1:200,000 per 1.7 ML Cartridge

articaine hydrochloride 40 MG / epinephrine bitartrate 1:200,000 per 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.009 MG/ML Cartridge


articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.009 MG/ML [Ultacan]

articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.009 MG/ML [Ultacan]


articaine / EPINEPHrine Cartridge [Ultacan]

articaine / epinephrine Cartridge [Ultacan]


1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.009 MG/ML Cartridge [Ultacan]

Ultacan 40 MG / 0.009 MG per 1.7 ML Cartridge

Ultacan 40 MG / 1:200,000 per 1.7 ML Cartridge

Ultacan 40 MG / 1:200,000 in 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.009 MG/ML Cartridge [Ultacan]


articaine hydrochloride 40 MG / epinephrine bitartrate 1:100,000 per 1.7 ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 1:100,000 per 1.7 ML Cartridge

articaine hydrochloride 40 MG / epinephrine bitartrate 0.018 MG per 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.018 MG/ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 1:100,000 in 1.7 ML Cartridge

articaine hydrochloride 40 MG / EPINEPHrine bitartrate 0.018 MG per 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge


articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.018 MG/ML [Ultacan]

articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML [Ultacan]


Ultacan forte 40 MG / 1:100,000 in 1.7 ML Cartridge

Ultacan 40 MG / 1:100,000 per 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine bitartrate 0.018 MG/ML Cartridge [Ultacan]

Ultacan 40 MG / 0.018 MG per 1.7 ML Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / epinephrine bitartrate 0.018 MG/ML Cartridge [Ultacan]


aloe polysaccharide 0.01 MG/MG / iodoquinol 0.0125 MG/MG [Quinja]


aloe polysaccharide / iodoquinol Topical Gel [Quinja]


Quinja 0.01 MG/MG / 0.0125 MG/MG Topical Gel

aloe polysaccharide 0.01 MG/MG / iodoquinol 0.0125 MG/MG Topical Gel [Quinja]


glutamine Powder for Oral Solution [Endari]


Endari 5 GM Powder for Oral Solution
Endari 5000 MG Powder for Oral Solution

glutamine 5000 MG Powder for Oral Solution [Endari]


daytime 10 (acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / nighttime 10 (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{10 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 10 (acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

daytime 10 (acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / nighttime 10 (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

{10 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 10 (acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


A fully human immunoglobulin G1 (IgG1) monoclonal antibody against plasma kallikrein that can be used for the treatment of hereditary angioedema (HAE). Upon administration, lanadelumab targets and binds to plasma kallikrein, thereby inhibiting its proteolytic activity. This inhibits the cleavage of high-molecular-weight-kininogen (HMWK) into cleaved HMWK (cHMWK) and bradykinin. This in turn may prevent bradykinin-driven vasodilation, the resulting increase in vascular permeability, and the swelling and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.


A humanized immunoglobulin G1 (IgG1) monoclonal antibody targeting the p19 subunit of human interleukin 23 (IL-23) cytokine, with anti-inflammatory activity. Upon administration, risankizumab targets and binds to the p19 subunit of human IL-23, inhibiting the interaction of IL-23 with the IL-23 receptor complex. This inhibits IL-23/IL-23 receptor-mediated signaling and inhibits the release of pro-inflammatory cytokines and chemokines. IL-23 plays an important role in the development, maintenance and activation of Th17 cells, which produce pro-inflammatory cytokines including IL-17A, IL-17F, and IL-22. It is upregulated in various inflammatory and autoimmune diseases.


An orally bioavailable inhibitor of the hepatitis C virus (HCV) non-structural protein 3/non-structural protein 4A (NS3/NS4A) serine protease, with antiviral activity. Upon administration, voxilaprevir binds to the HCV NS3/NS4A serine protease and prevents NS3/NS4A protease-mediated polyprotein maturation. This disrupts both the processing of viral proteins and the formation of the viral replication complex, thereby preventing viral replication and function. NS3, a serine protease, is essential for the proteolytic cleavage of multiple sites within the HCV polyprotein and plays a key role during HCV ribonucleic acid (RNA) replication. NS4A is an activating factor for NS3. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family; HCV infection is associated with the development of hepatocellular carcinoma (HCC).


An orally bioavailable, allosteric Bcr-Abl1 tyrosine kinase inhibitor, with antineoplastic activity. Upon administration, asciminib targets and binds to the myristoyl pocket of the Bcr-Abl1 fusion protein at a location that is distinct from the ATP-binding domain, thereby inhibiting the activity of both wild-type Bcr-Abl and certain mutation forms, including the T315I mutation. This binding results in the inhibition of Bcr-Abl1-mediated proliferation and enhanced apoptosis of Philadelphia chromosome-positive (Ph+) hematological malignancies. The Bcr-Abl1 fusion protein tyrosine kinase is an abnormal enzyme produced by leukemia cells that contain the Philadelphia chromosome.


amylases 90,750 UNT / endopeptidases 86,250 UNT / lipase 24,000 UNT Delayed Release Oral Capsule

lipase 24,000 UNT / amylase 90,750 UNT / protease 86,250 UNT Delayed Release Oral Capsule

amylase 90,750 UNT / lipase 24,000 UNT / protease 86,250 UNT Delayed Release Oral Capsule

amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule


amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT [Pertzye]


Pertzye 24,000 UNT / 90,750 UNT / 86,250 UNT / Delayed Release Oral Capsule

Pertzye (amylase 90,750 UNT / lipase 24,000 UNT / protease 86,250 UNT) Delayed Release Oral Capsule

Pertzye (amylases 90,750 UNT / endopeptidases 86,250 UNT / lipase 24,000 UNT) Delayed Release Oral Capsule

amylase 90750 UNT / lipase 24000 UNT / protease 86250 UNT Delayed Release Oral Capsule [Pertzye]


belimumab 200 MG per 1 ML Auto-Injector
belimumab 200 MG in 1 ML Auto-Injector


Benlysta 200 MG in 1 ML Auto-Injector
1 ML Benlysta 200 MG/ML Auto-Injector
Benlysta 200 MG per 1 ML Auto-Injector

1 ML belimumab 200 MG/ML Auto-Injector [Benlysta]


sofosbuvir / velpatasvir / voxilaprevir Oral Product


sofosbuvir / velpatasvir / voxilaprevir Pill


sofosbuvir / velpatasvir / voxilaprevir Oral Tablet


sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet


sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG [Vosevi]


sofosbuvir / velpatasvir / voxilaprevir Oral Tablet [Vosevi]


Vosevi 400 MG / 100 MG / 100 MG Oral Tablet

Vosevi 400/100/100 (sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG) Oral Tablet

sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi]


lidocaine 0.04 MG/MG / menthol 0.01 MG/MG [Lidozen]


lidocaine / menthol Topical Gel [Lidozen]


Lidozen 4 % / 1 % Topical Gel
LidozenGel 4 % / 1 % Topical Gel

lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel [Lidozen]


belimumab 200 MG in 1 ML Prefilled Syringe

belimumab 200 MG per 1 ML Prefilled Syringe

1 ML belimumab 200 MG/ML Prefilled Syringe


Benlysta 200 MG in 1 ML Prefilled Syringe

1 ML Benlysta 200 MG/ML Prefilled Syringe

Benlysta 200 MG per 1 ML Prefilled Syringe

1 ML belimumab 200 MG/ML Prefilled Syringe [Benlysta]


triprolidine HCl 1.25 MG Chewable Tablet

triprolidine hydrochloride 1.25 MG Chewable Tablet


An orally bioavailable inhibitor of the human epidermal growth factor receptor tyrosine kinase ErbB-2 (also called HER2) with potential antineoplastic activity. Tucatinib selectively binds to and inhibits the phosphorylation of ErbB-2, which may prevent the activation of ErbB-2 signal transduction pathways, resulting in growth inhibition and death of ErbB-2-expressing tumor cells. ErbB-2 is overexpressed in a variety of cancers and plays an important role in cellular proliferation and differentiation.


An acyclic nucleotide phosphonate prodrug and polymerase inhibitor that can potentially be used for its antineoplastic activity in the treatment of lymphoma in dogs. Upon administration, rabacfosadine is hydrolyzed intracellularly to 9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2, 6-diaminopurine (cPrPMEDAP) and subsequently deaminated to 9-(2-phosphonylmethoxyethyl) guanine (PMEG) and phosphorylated to PMEG diphosphate (PMEGpp). PMEGpp binds to and inhibits DNA polymerases. This inhibits DNA synthesis, resulting in S phase arrest and induction of apoptosis.


A selective retinoic acid receptor gamma (RAR gamma) agonist that can be used in the treatment of acne vulgaris. Upon topical application, trifarotene selectively binds to the RAR gamma receptor, thereby altering the expression of certain genes that are involved in inflammation and cellular differentiation.


An orally bioavailable small-molecule inhibitor of the Hedgehog (Hh) signaling pathway with potential antineoplastic activity. Glasdegib appears to inhibit Hh pathway signaling. The Hh signaling pathway plays an important role in cellular growth, differentiation and repair. Constitutive activation of Hh pathway signaling has been observed in various types of malignancies.


An orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Upon oral administration, erdafitinib binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells. FGFR, upregulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.


colloidal oatmeal 20 MG/ML Medicated Shampoo


Vaniply 0.02 MG/MG Topical Ointment
VANIPLY 2 % Topical Ointment

dimethicone 0.02 MG/MG Topical Ointment [Vaniply]


hydrogenated jojoba oil/jojoba oil, randomized (iodine value 64-70)


capsaicin 0.035 % / lidocaine 4 % / trolamine salicylate 10 % Topical Solution

capsaicin 0.35 MG/ML / lidocaine 40 MG/ML / trolamine salicylate 100 MG/ML Topical Solution


The mesylate salt form of enasidenib, an orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. Upon administration, enasidenib specifically inhibits various mutant forms of IDH2, including the IDH2 variants R140Q, R172S, and R172K, which inhibits the formation of 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH2-expressing tumor cells. IDH2, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by blocking differentiation and the production of the oncometabolite 2HG.


An orally available inhibitor of specific mutant forms of the mitochondrial enzyme isocitrate dehydrogenase type 2 (IDH2), with potential antineoplastic activity. Upon administration, enasidenib specifically inhibits various mutant forms of IDH2, including the IDH2 variants R140Q, R172S, and R172K, which inhibits the formation of 2-hydroxyglutarate (2HG). This may lead to both an induction of cellular differentiation and an inhibition of cellular proliferation in IDH2-expressing tumor cells. IDH2, an enzyme in the citric acid cycle, is mutated in a variety of cancers; it initiates and drives cancer growth by blocking differentiation and the production of the oncometabolite 2HG.


menthol 5 % / methyl salicylate 10 % Topical Cream

menthol 50 MG/ML / methyl salicylate 100 MG/ML Topical Cream


enasidenib 100 MG (as enasidenib mesylate 120 MG) Oral Tablet


Idhifa 100 MG (as enasidenib mesylate 120 MG) Oral Tablet


enasidenib 50 MG (as enasidenib mesylate 60 MG) Oral Tablet


Idhifa 50 MG (as enasidenib mesylate 60 MG) Oral Tablet


chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML [Vanacof AC]


chlophedianol / pyrilamine Oral Solution [Vanacof AC]


chlorhexidine gluconate 20 MG/ML / miconazole nitrate 20 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML [VetraSeb]


chlorhexidine / miconazole / salicyloyl phytosphingosine Medicated Shampoo [VetraSeb]


VetraSeb M 2 % / 2 % / 0.05 % Medicated Shampoo

VetraSeb (chlorhexidine gluconate 2 % / miconazole nitrate 2 % / salicyloyl phytosphingosine 0.05 % ) Medicated Shampoo

chlorhexidine gluconate 20 MG/ML / miconazole nitrate 20 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML Medicated Shampoo [VetraSeb]


dapagliflozin 2.5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet

dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet

24 HR dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet

24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet


dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG [Xigduo]

dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG [Xigduo]


24 HR dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet [Xigduo]

Xigduo XR 2.5/1000 24HR Extended Release Oral Tablet

24 HR dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Xigduo]


Altren 0.22 % Oral Solution
Altren 2.2 MG/ML Oral Solution

altrenogest 2.2 MG/ML Oral Solution [Altren]


The maleate salt form of neratinib, an orally available, quinazoline-based, irreversible inhibitor of both the receptor tyrosine kinases (RTKs) human epidermal growth factor receptor 2 (HER2; ERBB2) and human epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon administration, neratinib targets and covalently binds to the cysteine residue in the ATP-binding pockets of both HER2 and EGFR. This inhibits their activity and results in the inhibition of downstream signal transduction events, induces cell cycle arrest, apoptosis and ultimately decreases cellular proliferation in HER2- and EGFR-expressing tumor cells. EGFR and HER2, RTKs that are mutated or overactivated in many tumor cell types, play key roles in tumor cell proliferation and tumor vascularization.


neratinib 40 MG (as neratinib maleate 48.31 mg) Oral Tablet


Nerlynx 40 MG (as neratinib maleate 48.31 MG) Oral Tablet


A fixed dose combination of glecaprevir, an inhibitor of the hepatitis C virus (HCV) NS3/4A serine protease, and pibrentasvir, an inhibitor of the HCV non-structural protein 5A (NS5A), with activity against HCV genotypes 1-6. Upon oral administration of glecaprevir/pibrentasvir, glecaprevir inhibits the HCV NS3/4A serine protease enzyme, thereby disrupting the cleavage of the virally encoded polyprotein into mature proteins and preventing the formation of the viral replication complex. Pibrentasvir inhibits the activity of the NS5A protein, leading to disruption of the viral RNA replication complex, blockage of HCV RNA production, and inhibition of viral replication. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family; HCV infection is associated with the development of certain cancers.


glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet


glecaprevir 100 MG / pibrentasvir 40 MG [Mavyret]


glecaprevir / pibrentasvir Oral Tablet [Mavyret]


Mavyret (glecaprevir 100 MG / pibrentasvir 40 MG) Oral Tablet

glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]


A humanized immunoglobulin IgG1 kappa monoclonal antibody directed against the B-cell-specific membrane protein CD-19 with potential immunostimulating and antineoplastic activities. Inebilizumab binds to CD19, which may result in a cytotoxic T-lymphocyte (CTL) response and antibody-dependent cellular cytotoxicity (ADCC) to CD19-expressing B-cells. The Fc portion of inebilizumab does not contain a fucose sugar moiety, which may contribute to its enhanced ADCC activity. CD19 is a membrane antigen that is widely expressed during B-cell development, from pro-B-cell to early plasma cell stages.


dextromethorphan hydrobromide 9 MG / guaiFENesin 198 MG / phenylephrine hydrochloride 5 MG [Vanatab DM]

dextromethorphan hydrobromide 9 MG / guaifenesin 198 MG / phenylephrine hydrochloride 5 MG [Vanatab DM]


dextromethorphan / guaiFENesin / phenylephrine Oral Tablet [Vanatab DM]

dextromethorphan / guaifenesin / phenylephrine Oral Tablet [Vanatab DM]


chlophedianol hydrochloride 12.5 MG / pyrilamine maleate 25 MG [Vanatab AC]


chlophedianol / pyrilamine Oral Tablet [Vanatab AC]


An antibody drug conjugate (ADC) containing a human monoclonal antibody AGS-22 targeting the cell adhesion molecule nectin-4 and conjugated to the cytotoxic agent monomethyl auristatin E (MMAE), via a proprietary enzyme-cleavable linker (AGS-22CE), with potential antineoplastic activity. The monoclonal antibody moiety of enfortumab vedotin selectively binds to nectin-4. After internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and induces apoptosis in nectin-4 overexpressing tumor cells. Nectin-4, a tumor associated antigen belonging to the nectin family, is overexpressed in a variety of cancers, including breast, bladder, lung and pancreatic cancer.


SwineMate 0.22 % Oral Solution
Swinemate 0.22 % Oral Solution
Swinemate 2.2 MG/ML Oral Solution

altrenogest 2.2 MG/ML Oral Solution [Swinemate]


chloroxylenol 0.1 % Medicated Liquid Soap

chloroxylenol 1 MG/ML Medicated Liquid Soap


Nityr 10 MG Oral Tablet
NITYR 10 MG Oral Tablet


NITYR 5 MG Oral Tablet
Nityr 5 MG Oral Tablet


NITYR 2 MG Oral Tablet
Nityr 2 MG Oral Tablet


minocycline Extended Release Oral Tablet [Minolira]


lanolin 15.5 % / petrolatum 30 % Topical Ointment

lanolin 15.5 GM per 100 GM / petrolatum 30 GM per 100 GM Topical Ointment

lanolin 0.155 MG/MG / petrolatum 0.3 MG/MG Topical Ointment


fluticasone propionate 0.113 MG/ACTUAT [Armonair]


fluticasone Dry Powder Inhaler [Armonair]


menthol / methyl salicylate / synthetic camphor


fluticasone propionate 0.232 MG/ACTUAT [Armonair]


fluticasone propionate 0.055 MG/ACTUAT [Armonair]


ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule


Penicillium chrysogenum var. chrysogenum allergenic extract 200 MG/ML


Penicillium notatum allergenic extract 0.2 GM/ML Injectable Solution

Penicillium chrysogenum var. chrysogenum extract 0.2 GM/ML Injectable Solution

Penicillium chrysogenum var. chrysogenum allergenic extract 200 MG/ML Injectable Solution


influenza B virus B/Brisbane/46/2015 antigen


influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen / influenza B virus B/Brisbane/46/2015 antigen / influenza B virus B/Phuket/3073/2013 antigen


LolliCaine 20 % Oral Gel
LolliCaine 0.2 MG/MG Oral Gel
LolliCaine 20 % Dental Gel

benzocaine 0.2 MG/MG Oral Gel [LolliCaine]


methyl salicylate 200 MG/ML Topical Solution


diphenhydrAMINE / pramoxine Topical Spray

diphenhydramine / pramoxine Topical Spray


diphenhydrAMINE hydrochloride 1 % / pramoxine hydrochloride 1 % Topical Spray

diphenhydrAMINE hydrochloride 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Spray

diphenhydramine hydrochloride 1 % / pramoxine hydrochloride 1 % Topical Spray

diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray

diphenhydramine hydrochloride 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Spray


Menthol 4.5 MG/ML / ZNO 200 MG/ML Rectal Cream

menthol 0.45 % / zinc oxide 20 % Rectal Cream

menthol 4.5 MG/ML / zinc oxide 200 MG/ML Rectal Cream


ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection

ara-C liposome 100 MG / DAUNOrubicin Liposomal 44 MG Injection

cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG Injection

cytarabine 100 MG / daunorubicin 44 MG Liposome Injection

cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection

cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection


cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG [Vyxeos]

cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos]


ara-C liposome 100 MG / DAUNOrubicin Liposomal 44 MG Injection [Vyxeos]

ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection [Vyxeos]

Vyxeos 44 MG / 100 MG Liposome Injection

cytarabine liposome 100 MG / DAUNOrubicin liposomal 44 MG Injection [Vyxeos]

cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos]


coal tar 10 MG/ML / salicylic acid 20 MG/ML / sulfur 20 MG/ML [Ala Seb T]


coal tar / salicylic acid / sulfur Medicated Shampoo [Ala Seb T]


bismuth subgallate Chewable Tablet [Devrom]


bismuth subgallate 200 MG Chewable Tablet [Devrom]


inotuzumab ozogamicin Injectable Product


inotuzumab ozogamicin Injection [Besponsa]


Besponsa 0.9 MG Injection
BESPONSA 0.9 MG Injection

inotuzumab ozogamicin 0.9 MG Injection [Besponsa]


timolol 0.5 % (as timolol maleate 6.8 MG/ML) 24 HR Ophthalmic Solution

24 HR timolol 5 MG/ML Ophthalmic Solution


dicarboxylic acid or its salts or esters involved in the metabolism of tryptophan and lysine.


Abuse-Deterrent oxyCODONE hydrochloride 5 MG Oral Tablet [Roxybond]

Abuse-Deterrent oxycodone hydrochloride 5 MG Oral Tablet [Roxybond]


{24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Chewable Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Melodetta 24 Fe Chewable 28 Day]


3-Month 1.5 ML leuprolide acetate 20 MG/ML Prefilled Syringe

leuprolide acetate 30 MG in 1.5 ML (3 month) Prefilled Syringe

1.5 ML leuprolide acetate 20 MG/ML (3 month) Prefilled Syringe

leuprolide acetate 30 MG per 1.5 ML (3 month) Prefilled Syringe


Temovate E 0.5 MG/ML Topical Cream
Temovate E 0.05 % Topical Cream

Emollient clobetasol propionate 0.5 MG/ML Topical Cream [Temovate]


Tarsum Reformulated 20 MG/ML Medicated Shampoo

coal tar 20 MG/ML Medicated Shampoo [Tarsum Reformulated]


wild rhubarb root extract
Arctium minus root extract


Emollient clobetasol propionate 0.5 MG/ML Topical Foam

clobetasol propionate 0.05 % Emollient Base Topical Foam


Emollient clobetasol propionate 0.5 MG/ML Topical Foam [Olux]


methadone hydrochloride 40 MG Tablet for Oral Suspension [Diskets]

DISKETS 40 MG Tablet for Oral Suspension

Diskets 40 MG Tablet for Oral Suspension


traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet

Matrix Delivery 24 HR traMADol hydrochloride 300 MG Extended Release Oral Tablet

tramadol hydrochloride 300 MG Matrix Delivery 24 HR Extended Release Oral Tablet

Matrix Delivery 24 HR tramadol hydrochloride 300 MG Extended Release Oral Tablet

traMADol hydrochloride 300 MG Matrix Delivery 24 HR Extended Release Oral Tablet


Matrix Delivery 24 HR tramadol hydrochloride 200 MG Extended Release Oral Tablet

traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet

tramadol hydrochloride 200 MG Matrix Delivery 24 HR Extended Release Oral Tablet

Matrix Delivery 24 HR traMADol hydrochloride 200 MG Extended Release Oral Tablet

traMADol hydrochloride 200 MG Matrix Delivery 24 HR Extended Release Oral Tablet


LUPRON DEPOT-PED 30 MG in 1.5 ML (3 month) Prefilled Syringe

1.5 ML Lupron Depot-Ped 20 MG/ML (3 month) Prefilled Syringe

Lupron Depot-Ped 30 MG per 1.5 ML (3 month) Prefilled Syringe

3-Month 1.5 ML leuprolide acetate 20 MG/ML Prefilled Syringe [Lupron]


Matrix Delivery 24 HR tramadol hydrochloride 100 MG Extended Release Oral Tablet

tramadol hydrochloride 100 MG Matrix Delivery 24 HR Extended Release Oral Tablet

traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet

traMADol hydrochloride 100 MG Matrix Delivery 24 HR Extended Release Oral Tablet

Matrix Delivery 24 HR traMADol hydrochloride 100 MG Extended Release Oral Tablet


{20 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 10 (acetaminophen 325 MG / diphenhydrAMINE hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

{20 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 10 (acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack

20 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 10 nighttime (acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack

20 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 10 nighttime (acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet) Pack


12 HR timolol 5 MG/ML Ophthalmic Solution [Timoptic]

Timoptic 5 MG (timolol maleate 6.8 MG) per ML 12 HR Ophthalmic Solution

Timoptic 0.5 % 12 HR Ophthalmic Solution


clobetasol propionate 0.05 % Emollient Base Topical Cream

Emollient clobetasol propionate 0.5 MG/ML Topical Cream


capsaicin 0.00025 MG/MG Medicated Patch [Satogesic Hot]


methotrexate 25 MG/ML Injectable Solution

methotrexate 25 MG/mL Injectable Solution

methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution


dextrose 50 % in 100 ML Injection
dextrose 50 % per 100 ML Injection


dexamethasone 1.5 MG Tablet 12 Day 49 Count Pack

{49 (dexamethasone 1.5 MG Oral Tablet) } Pack


cetirizine hydrochloride 10 MG Oral Tablet [Aller-Tec]


CLENPIQ 10 MG / 3.5 GM / 12 GM in 160 mL Oral Solution

CLENPIQ (citric acid 12 GM / magnesium oxide 3.5 GM / picosulfate sodium 10 MG) per 160 ML Oral Solution

citric acid 75 MG/ML / magnesium oxide 21.9 MG/ML / picosulfate sodium 0.0625 MG/ML Oral Solution [Clenpiq]


OZEMPIC 2 MG in 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose

0.25 MG, 0.5 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic]

0.25 MG, 0.5 MG Dose 1.5 ML Ozempic 1.34 MG/ML Pen Injector

OZEMPIC 2 MG per 1.5 ML Pen Injector, 0.25 or 0.5 MG Dose


1 MG Dose 1.5 ML Ozempic 1.34 MG/ML Pen Injector

1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic]

OZEMPIC 2 MG per 1.5 ML Pen Injector, 1 MG Dose

OZEMPIC 2 MG in 1.5 ML Pen Injector, 1 MG Dose


24 ML nivolumab 10 MG/ML Injection [Opdivo]


Hemlibra 60 MG in 0.4 mL Injection
Hemlibra 60 MG per 0.4 ML Injection
Hemlibra 150 MG/ML per 0.4 ML Injection

0.4 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra]


1 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra]


insulin aspart, human 100 UNT/ML Injectable Solution [Fiasp]


3 ML insulin aspart, human 100 UNT/ML Pen Injector [Fiasp]


Zenpep 40,000 UNT / 168,000 UNT / 126,000 UNT Delayed Release Oral Capsule

amylase 168000 UNT / lipase 40000 UNT / protease 126000 UNT Delayed Release Oral Capsule [Zenpep]

Zenpep (amylases 168,000 UNT / endopeptidases 126,000 UNT / lipase 40,000 UNT) Delayed Release Oral Capsule

Zenpep (amylase 168,000 UNT / lipase 40,000 UNT / protease 126,000 UNT) Delayed Release Oral Capsule


lipase 40,000 UNT / amylase 168,000 UNT / protease 126,000 UNT Delayed Release Oral Capsule Category : Capsule

amylase 168000 UNT / lipase 40000 UNT / protease 126000 UNT Delayed Release Oral Capsule

amylases 168,000 UNT / endopeptidases 126,000 UNT / lipase 40,000 UNT Delayed Release Oral Capsule


Prevymis 20 MG/ML per 12 ML Injection
PREVYMIS 240 MG in 12 ML Injection
Prevymis 240 MG per 12 ML Injection

12 ML letermovir 20 MG/ML Injection [Prevymis]


Prevymis 480 MG per 24 ML Injection
Prevymis 20 MG/ML per 24 ML Injection
Prevymis 480 MG in 24 ML Injection

24 ML letermovir 20 MG/ML Injection [Prevymis]


0.7 ML emicizumab-kxwh 150 MG/ML Injection [Hemlibra]


Admelog 100 UNT/ML per 3 ML Pen Injector

3 ML insulin lispro 100 UNT/ML Pen Injector [Admelog]


insulin lispro 100 UNT/ML Injectable Solution [Admelog]


QVAR Redihaler 80 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT

Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.08 MG/ACTUAT Metered Dose Inhaler [Qvar]

Breath-Actuated 120 ACTUAT Qvar 0.08 MG/ACTUAT Metered Dose Inhaler


QVAR Redihaler 40 MCG/ACTUAT Breath-Actuated Metered Dose Inhaler, 120 ACTUAT

Breath-Actuated 120 ACTUAT Qvar 0.04 MG/ACTUAT Metered Dose Inhaler

Breath-Actuated 120 ACTUAT beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler [Qvar]


brigatinib 180 MG Oral Tablet (23) / brigatinib 90 MG Oral Tablet (7) Pack

{23 (brigatinib 180 MG Oral Tablet) / 7 (brigatinib 90 MG Oral Tablet) } Pack


Alunbrig Initiation Pack
ALUNBRIG Initiation Pack

{23 (brigatinib 180 MG Oral Tablet [Alunbrig]) / 7 (brigatinib 90 MG Oral Tablet [Alunbrig]) } Pack [Alunbrig Initiation Pack]


{74 (apixaban 5 MG Oral Tablet [Eliquis]) } Pack [Eliquis 30-Day Starter Pack]


TaperDex 1.5 MG Tablet 12 Day 49 Count Pack

{49 (dexamethasone 1.5 MG Oral Tablet) } Pack [TaperDex 12 Day Taper]


TaperDex 1.5 MG Tablet 6 Day 21 Count Pack

{21 (dexamethasone 1.5 MG Oral Tablet) } Pack [TaperDex 6 Day Taper]


{21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Balcoltra 28 Day]


{28 (ivacaftor 150 MG / tezacaftor 100 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack

ivacaftor 150 MG / tezacaftor 100 MG (28) Oral Tablet / ivacaftor 150 MG (28) Oral Tablet Pack


{28 (ivacaftor 150 MG / tezacaftor 100 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Symdeko (100 MG / 150 MG; 150 MG)]


{21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Tydemy 28 Day]


axicabtagene ciloleucel 200,000,000 CELLS per 68 ML Injection

68 ML axicabtagene ciloleucel 2940000 CELLS/ML Injection

axicabtagene ciloleucel 200,000,000 CELLS in 68 mL Injection


Vabomere (meropenem / vaborbactam) 2 GM Injection

meropenem 1000 MG / vaborbactam 1000 MG Injection [Vabomere]


amantadine 68.5 MG 24HR Extended Release Oral Capsule

amantadine 68.5 MG (as amantadine HCl 85 MG) 24 HR Extended Release Oral Capsule

24 HR amantadine 68.5 MG Extended Release Oral Capsule


meropenem 1 GM / vaborbactam 1 GM Injection

meropenem 1000 MG / vaborbactam 1000 MG Injection


zinc oxide 0.4 MG/MG [Aquaphor Diaper Rash]


ZNO 0.4 MG/MG Paste [Aquaphor Diaper Rash]

zinc oxide 0.4 MG/MG Paste [Aquaphor Diaper Rash]


spironolactone Oral Suspension [Carospir]


CaroSpir 25 MG in 5 mL Oral Suspension
Carospir 25 MG per 5 ML Oral Suspension
Carospir 5 MG/ML Oral Suspension

spironolactone 5 MG/ML Oral Suspension [Carospir]


vitamin A acetate 10,000 UNT Sublingual Tablet

retinol acetate 10000 UNT Sublingual Tablet


hydroxydecyl ubiquinoyl dipalmitoyl glycerate


chlophedianol / pseudoephedrine / pyrilamine Oral Liquid Product


chlophedianol / pseudoephedrine / pyrilamine Oral Product


chlophedianol / pseudoephedrine / pyrilamine Oral Solution


chlophedianol / pseudoephedrine / pyrilamine


chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution

chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG / pyrilamine maleate 12.5 MG per 5 mL Oral Solution

chlophedianol hydrochloride 2.5 MG/ML / pseudoephedrine hydrochloride 6 MG/ML / pyrilamine maleate 2.5 MG/ML Oral Solution


tisagenlecleucel-T 250,000,000 CELLS Injection [Kymriah]

tisagenlecleucel 250000000 CELLS Injection [Kymriah]


influenza A virus A/Slovenia/2903/2015 (H1N1) antigen


benzyl alcohol / lidocaine Topical Solution


benzyl alcohol 10 % / lidocaine HCl 4 % Topical Solution

benzyl alcohol 0.1 ML/ML / lidocaine hydrochloride 40 MG/ML Topical Solution


tisagenlecleucel 250000000 CELLS Injection

tisagenlecleucel-T 250,000,000 CELLS Injection


acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Arthriten Max]


acetaminophen / aspirin / caffeine Oral Tablet [Arthriten Max]


Arthriten Max 250 MG / 250 MG / 65 MG Oral Tablet

Arthriten Max (acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG) Oral Tablet

APAP 250 MG / ASA 250 MG / Caffeine 65 MG Oral Tablet [Arthriten Max]

acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet [Arthriten Max]


FloLipid 20 MG in 5 mL Oral Suspension
Flolipid 4 MG/ML Oral Suspension
Flolipid 20 MG per 5 mL Oral Suspension

simvastatin 4 MG/ML Oral Suspension [Flolipid]


FloLipid 40 MG in 5 mL Oral Suspension
Flolipid 8 MG/ML Oral Suspension
Flolipid 40 MG per 5 mL Oral Suspension

simvastatin 8 MG/ML Oral Suspension [Flolipid]


amantadine Extended Release Oral Capsule


amantadine 137 MG 24HR Extended Release Oral Capsule

amantadine 137 MG (as amantadine HCl 170 MG) 24 HR Extended Release Oral Capsule

24 HR amantadine 137 MG Extended Release Oral Capsule


amantadine Extended Release Oral Capsule [Gocovri]


GOCOVRI 137 MG 24HR Extended Release Oral Capsule

24 HR Gocovri 137 MG Extended Release Oral Capsule

Gocovri 137 MG (as amantadine HCl 170 MG) 24 HR Extended Release Oral Capsule

24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri]


24 HR Gocovri 68.5 MG Extended Release Oral Capsule

GOCOVRI 68.5 MG 24HR Extended Release Oral Capsule

Gocovri 68.5 MG (amantadine HCl 85 MG) 24 HR Extended Release Oral Capsule

24 HR amantadine 68.5 MG Extended Release Oral Capsule [Gocovri]


triptorelin 22.5 MG Injection [Triptodur]


oxycodone hydrochloride 15 MG (equivalent to oxycodone 13.4 MG) Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxyCODONE hydrochloride 15 MG Oral Tablet

oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent

oxyCODONE hydrochloride 15 MG (equivalent to oxyCODONE 13.4 MG) Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet


oxyCODONE hydrochloride 15 MG [Roxybond]

oxycodone hydrochloride 15 MG [Roxybond]


Abuse-Deterrent oxyCODONE hydrochloride 15 MG Oral Tablet [Roxybond]

Abuse-Deterrent oxycodone hydrochloride 15 MG Oral Tablet [Roxybond]


oxycodone hydrochloride 30 MG (equivalent to oxycodone 26.9 MG) Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxyCODONE hydrochloride 30 MG Oral Tablet

oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent

oxyCODONE hydrochloride 30 MG (equivalent to oxyCODONE 26.9 MG) Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxycodone hydrochloride 30 MG Oral Tablet


oxyCODONE hydrochloride 30 MG [Roxybond]

oxycodone hydrochloride 30 MG [Roxybond]


Abuse-Deterrent oxyCODONE hydrochloride 30 MG Oral Tablet [Roxybond]

Abuse-Deterrent oxycodone hydrochloride 30 MG Oral Tablet [Roxybond]


oxyCODONE hydrochloride 5 MG (equivalent to oxyCODONE 4.5 MG) Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxyCODONE hydrochloride 5 MG Oral Tablet

oxycodone hydrochloride 5 MG (equivalent to oxycodone 4.5 MG) Oral Tablet, Abuse-Deterrent

oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent

Abuse-Deterrent oxycodone hydrochloride 5 MG Oral Tablet


camphor 0.8 % / menthol 0.8 % / petrolatum 30 % Topical Stick

camphor 0.008 MG/MG / menthol 0.008 MG/MG / petrolatum 0.3 MG/MG Topical Ointment


trientine hydrochloride 250 MG [Syprine]


thioctic acid 50 MG / tocopherol,DL-alpha 100 UNT / ubidecarenone 30 MG [Q-Gel with Lipoic Acid]


ubidecarenone 100 MG / vitamin E 150 UNT [Q-Gel]


miconazole nitrate 2 % Medicated Shampoo

miconazole nitrate 20 MG/ML Medicated Shampoo


gemtuzumab ozogamicin Injection [Mylotarg]


Mylotarg 4.5 MG Injection
MYLOTARG 4.5 MG Injection

gemtuzumab ozogamicin 4.5 MG Injection [Mylotarg]


lesinurad 200 MG / allopurinol 300 MG Oral Tablet

allopurinol 300 MG / lesinurad 200 MG Oral Tablet


allopurinol 300 MG / lesinurad 200 MG [Duzallo]


allopurinol / lesinurad Oral Tablet [Duzallo]


Duzallo (lesinurad 200 MG / allopurinol 300 MG) Oral Tablet

allopurinol 300 MG / lesinurad 200 MG Oral Tablet [Duzallo]


lesinurad 200 MG / allopurinol 200 MG Oral Tablet

allopurinol 200 MG / lesinurad 200 MG Oral Tablet


allopurinol 200 MG / lesinurad 200 MG [Duzallo]


Duzallo (lesinurad 200 MG / allopurinol 200 MG) Oral Tablet

allopurinol 200 MG / lesinurad 200 MG Oral Tablet [Duzallo]


ocriplasmin 0.375 MG in 0.3 ML Injection

ocriplasmin 0.375 MG per 0.3 ML Injection


Jetrea 0.375 MG per 0.3 ML Injection
JETREA 0.375 MG in 0.3 ML Injection

0.3 ML ocriplasmin 1.25 MG/ML Injection [Jetrea]


alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Product


alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Pill


alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule


alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate


fluticasone / umeclidinium / vilanterol Inhalant Product


fluticasone / umeclidinium / vilanterol Dry Powder Inhaler


fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters

fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT

14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler


fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT [Trelegy]


fluticasone / umeclidinium / vilanterol Dry Powder Inhaler [Trelegy]


TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters

Trelegy Ellipta (fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT

14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]


fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUA

fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUAT

30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler


Trelegy Ellipta (fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT

TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters

30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]


magnesium sulfate 0.4 MG/MG Topical Ointment


ZNO 170 MG/ML Topical Cream
zinc oxide 17 % Topical Cream


melatonin 3 MG / threonine 200 MG Chewable Tablet


Na-zone 6.5 MG/ML Nasal Spray
NaCl 6.5 MG/ML Nasal Spray [Na-zone]
Na-zone 0.65 % Nasal Spray
NA-ZONE 0.65 % Nasal Spray
Na-zone 0.111 MEQ/ML Nasal Spray

sodium chloride 6.5 MG/ML Nasal Spray [Na-zone]


5-hydroxytryptophan / melatonin Oral Product


5-hydroxytryptophan / melatonin Oral Tablet


melatonin 6 MG / 5-hydroxytryptophan 50 MG Oral Tablet

5-hydroxytryptophan 50 MG / melatonin 6 MG Oral Tablet


meropenem / vaborbactam Injectable Product


An orally available, tropomyosin receptor kinase (Trk) inhibitor, with potential antineoplastic activity. Upon administration, larotrectinib binds to Trk, thereby preventing neurotrophin-Trk interaction and Trk activation, which results in both the induction of cellular apoptosis and the inhibition of cell growth in tumors that overexpress Trk. Trk, a receptor tyrosine kinase activated by neurotrophins, is mutated in a variety of cancer cell types and plays an important role in tumor cell growth and survival.


A small molecule, competitive inhibitor of cyclin dependent kinases 4 and 6 (CDK4/6), with potential antineoplastic and chemoprotective activities. Upon intravenous administration, trilaciclib binds to and inhibits the activity of CDK4/6, thereby blocking the phosphorylation of the retinoblastoma protein (Rb) in early G1. This prevents G1/S phase transition, causes cell cycle arrest in the G1 phase, induces apoptosis, and inhibits the proliferation of CDK4/6-overexpressing tumor cells. In patients with CDK4/6-independent tumor cells, G1T28 may protect against multi-lineage chemotherapy-induced myelosuppression (CIM) by transiently and reversibly inducing G1 cell cycle arrest in hematopoietic stem and progenitor cells (HSPCs) and preventing transition to the S phase. This protects all hematopoietic lineages, including red blood cells, platelets, neutrophils and lymphocytes, from the DNA-damaging effects of certain chemotherapeutics and preserves the function of the bone marrow and the immune system. CDKs are serine/threonine kinases involved in the regulation of the cell cycle and may be overexpressed in certain cancer cell types. HSPCs are dependent upon CDK4/6 for proliferation.


A humanized monoclonal immunoglobulin G1 anti-P-selectin antibody with vaso-protective and anti-vaso-occlusive properties. Upon administration, crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand-1 (PSGL-1; SELPLG) on neutrophils and monocytes. P-selectin, a glycoprotein that functions as a cell adhesion molecule (CAM), translocates to the surface of activated endothelial cells and platelets, upon stimulation, where it binds to its ligand and mediates the rolling of platelets and neutrophils on activated endothelial cells. Therefore, blockade of p-selectin may inhibit platelet aggregation, maintain blood flow and minimize sickle cell-related pain crises (SCPC).


The hydrochloride salt form of capmatinib, an orally bioavailable inhibitor of the proto-oncogene c-Met (also known as hepatocyte growth factor receptor (HGFR)) with potential antineoplastic activity. Capmatinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.


Zeltnera venusta whole flowering extract


acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG [Phrenilin Forte]


acetaminophen / butalbital / caffeine Oral Capsule [Phrenilin Forte]


APAP 300 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule [Phrenilin Forte]

Phrenilin Forte (acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG) Oral Capsule

Phrenilin Forte 50 MG / 300 MG / 40 MG Oral Capsule

acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Phrenilin Forte]


amphetamine 1.25 MG/mL Extended Release Suspension

amphetamine 1.25 MG/ML Extended Release Suspension


amphetamine Extended Release Suspension [Adzenys]


Adzenys ER 1.25 MG/ML Extended Release Suspension

amphetamine 1.25 MG/ML Extended Release Suspension [Adzenys]


bosentan 32 MG Tablet for Oral Suspension


vigabatrin Powder for Oral Solution [Sabril]


lanolin / menthol / petrolatum / zinc oxide Topical Ointment


lanolin / menthol / petrolatum / zinc oxide


lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment

Lanolin 0.157 MG/MG / Menthol 0.0044 MG/MG / Petrolatum 0.24 MG/MG / ZNO 0.206 MG/MG Topical Ointment

lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG Topical Ointment


lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG [Calmoseptine]


capsaicin 0.03 % / menthol 3 % / methyl salicylate 10 % Topical Cream

capsaicin 0.3 MG/ML / menthol 30 MG/ML / methyl salicylate 100 MG/ML Topical Cream


fluticasone propionate 93 MCG/ACTUAT Metered Dose Nasal Spray

fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray


fluticasone propionate 0.093 MG/ACTUAT [Xhance]


fluticasone Metered Dose Nasal Spray [Xhance]


Xhance 93 MCG/ACTUAT Metered Dose Nasal Spray

XHANCE 93 MCG/ACTUAT Metered Dose Nasal Spray

Xhance 0.093 MG/ACTUAT Metered Dose Nasal Spray

fluticasone propionate 0.093 MG/ACTUAT Metered Dose Nasal Spray [Xhance]


meropenem 1000 MG / vaborbactam 1000 MG [Vabomere]


meropenem / vaborbactam Injection [Vabomere]


Solosec 2 GM Oral Granules
Solosec 2000 MG Oral Granules

secnidazole 2000 MG Oral Granules [Solosec]


zinc oxide 220 MG/ML [Benson's Bottom Paint]


zinc oxide Topical Cream [Benson's Bottom Paint]


ZNO 220 MG/ML Topical Cream [Benson's Bottom Paint]

Benson's Bottom Paint 22 % Topical Cream

Benson's Bottom Paint 220 MG/ML Topical Cream

zinc oxide 220 MG/ML Topical Cream [Benson's Bottom Paint]


chloroprocaine HCl 1 % in 5 ML Injection

chloroprocaine HCl 1 % per 5 ML Injection

5 ML chloroprocaine hydrochloride 10 MG/ML Injection


chloroprocaine hydrochloride 10 MG/ML [Clorotekal]


5 ML Clorotekal 10 MG/ML Injection
Clorotekal 1 % in 5 ML Injection

5 ML chloroprocaine hydrochloride 10 MG/ML Injection [Clorotekal]


hypromellose 3.5 MG/ML Ophthalmic Solution


abemaciclib 50 MG Oral Tablet [Verzenio]


abemaciclib 100 MG Oral Tablet [Verzenio]


abemaciclib 150 MG Oral Tablet [Verzenio]


abemaciclib 200 MG Oral Tablet [Verzenio]


influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Oral Tablet

dexbrompheniramine maleate 2 MG / dextromethorphan hydrobromide 20 MG / phenylephrine hydrochloride 10 MG Oral Tablet


influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML


triamcinolone acetonide 32 MG Extended-Release Injection


triamcinolone acetonide 32 MG [Zilretta]


Zilretta 32 MG Extended-Release Injection

triamcinolone acetonide 32 MG Injection [Zilretta]


butorphanol Injectable Solution [Torphaject]


TorphaJect 10 MG/ML Injectable Solution
Torphaject 10 MG/ML Injectable Solution

butorphanol 10 MG/ML Injectable Solution [Torphaject]


poly(DL-lactic-co-glycolic acid) (75:25; 140000 MW)


lidocaine hydrochloride 41.2 MG/ML Topical Cream


histamine / menthol / methyl salicylate Topical Product


histamine / menthol / methyl salicylate Topical Cream


histamine dihydrochloride 0.050 % / menthol 10 % / methyl salicylate 10 % Topical Cream

histamine dihydrochloride 0.5 MG/ML / menthol 100 MG/ML / methyl salicylate 100 MG/ML Topical Cream


palonosetron HCl 0.25 MG per 2 ML Injection


fibryga 1 MG Injection
Fibryga 1 MG Injection

fibrinogen, human 1 MG Injection [Fibryga]


2-phenylpropanal propylene glycol acetal


valbenazine (as valbenazine tosylate) 80 MG Oral Capsule


INGREZZA 80 MG Oral Capsule
Ingrezza 80 MG Oral Capsule

valbenazine 80 MG Oral Capsule [Ingrezza]


insulin aspart, human 100 UNT/ML [Fiasp]


insulin aspart, human Injectable Solution [Fiasp]


insulin aspart, human Pen Injector [Fiasp]


salicylic acid 280 MG/ML Topical Solution


Xalix 280 MG/ML Topical Solution
XALIX 28 % Topical Solution

salicylic acid 280 MG/ML Topical Solution [Xalix]


PEG-10 acrylate-perfluorohexylethyl acrylate copolymer


olive oil / soybean oil Injectable Product


olive oil 16 % / soybean oil 4 % in 1000 mL Injection

olive oil 16 % / soybean oil 4 % per 1000 ML Injection

1000 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection


olive oil 160 MG/ML / soybean oil 40 MG/ML [Clinolipid]


olive oil / soybean oil Injection [Clinolipid]


Clinolipid 20 % in 1000 mL Injection
Clinolipid 20 % per 1000 ML Injection

1000 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]


olive oil 16 % / soybean oil 4 % per 500 ML Injection

olive oil 16 % / soybean oil 4 % in 500 mL Injection

500 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection


Clinolipid 20 % per 500 ML Injection
Clinolipid 20 % in 500 mL Injection

500 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]


olive oil 16 % / soybean oil 4 % per 250 ML Injection

olive oil 16 % / soybean oil 4 % in 250 mL Injection

250 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection


Clinolipid 20 % per 250 ML Injection
Clinolipid 20 % in 250 mL Injection

250 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]


olive oil 16 % / soybean oil 4 % in 100 mL Injection

olive oil 16 % / soybean oil 4 % per 100 ML Injection

100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection


Clinolipid 20 % per 100 ML Injection
Clinolipid 20 % in 100 mL Injection

100 ML olive oil 160 MG/ML / soybean oil 40 MG/ML Injection [Clinolipid]


tisagenlecleucel 250000000 CELLS [Kymriah]


lanolin / menthol / petrolatum / zinc oxide Topical Ointment [Calmoseptine]


{21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Aurovela Fe 1.5/30 28 Day]


capromorelin 30 MG in 1 ML Oral Solution


Entyce 30 MG/ML Oral Solution
entyce 30 MG in 1 ML Oral Solution

capromorelin 30 MG/ML Oral Solution [Entyce]


acalabrutinib 100 MG Oral Capsule [Calquence]


varicella zoster virus glycoprotein E, recombinant


varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML


varicella zoster virus glycoprotein E Injectable Product


varicella zoster virus glycoprotein E Injection


0.5 ML zoster vaccine, recombinant 0.1 MG/ML

varicella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL Injection

0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection


varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML [Shingrix]


varicella zoster virus glycoprotein E Injection [Shingrix]


0.5 ML Shingrix 0.1 MG/ML Injection
Shingrix vaccine 0.5 ML Injection
SHINGRIX vaccine 0.5 ML Injection

0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix]


poloxamer 188 200 MG/ML Topical Solution


poloxamer 188 Topical Solution [Shur-Clens]


Shur-Clens 20 % Topical Solution
Shur-Clens 200 MG/ML Topical Solution

poloxamer 188 200 MG/ML Topical Solution [Shur-Clens]


rolapitant 166.5 MG per 92.5 ML Injection

rolapitant 166.5 MG in 92.5 ML Injection

rolapitant 166.5 MG (equivalent to rolapitant HCl 185 MG) per 92.5 ML Injection


Varubi 166.5 MG (equivalent to rolapitant HCl 185 MG) per 92.5 ML Injection

92.5 ML rolapitant 1.8 MG/ML Injection [Varubi]


capsaicin / lidocaine / trolamine salicylate Topical Product


capsaicin / lidocaine / trolamine salicylate Topical Solution


capsaicin / lidocaine / trolamine salicylate


hydrocortisone Topical Ointment [Cortizone]


hydrocortisone Topical Cream [Cortizone]


hydrocortisone Topical Lotion [Cortizone]


hydrocortisone Topical Solution [Cortizone]


vitamin E (water-soluble) 75 UNT in 1 mL Oral Solution

vitamin E (as d-alpha tocopheryl polyethylene glycol 1000 succinate) 75 UNT per 1 mL Oral Solution


choline 300 MG (as choline bitrate 750 MG) Extended Release Oral Tablet

choline 300 MG Extended Release Oral Tablet


niacin 500 MG / pantethine 200 MG Extended Release Oral Tablet

vitamin B3 500 MG / pantethine 200 MG Extended Release Oral Tablet

vit-B3 500 MG / pantethine 200 MG Extended Release Oral Tablet

nicotinic acid 500 MG / pantethine 200 MG Extended Release Oral Tablet


axicabtagene ciloleucel Injectable Product


axicabtagene ciloleucel Injection [Yescarta]


68 ML Yescarta 2940000 CELLS/ML Injection

YESCARTA 200,000,000 CELLS in 68 mL Injection

Yescarta 200,000,000 CELLS per 68 ML Injection

68 ML axicabtagene ciloleucel 2940000 CELLS/ML Injection [Yescarta]


camphor 3 % / menthol 10 % Topical Solution

camphor 30 MG/ML / menthol 100 MG/ML Topical Solution


0.85 ML Bydureon 2.35 MG/ML Auto-Injector

BYDUREON BCise 2 MG in 0.85 mL Auto-Injector

Bydureon Bcise 2 MG per 0.85 ML Auto-Injector

0.85 ML exenatide 2.35 MG/ML Auto-Injector [Bydureon]


3 ML Durolane 20 MG/ML Prefilled Syringe

DUROLANE 60 MG in 3 mL Prefilled Syringe

Durolane 60 MG per 3 ML Prefilled Syringe

3 ML sodium hyaluronate 20 MG/ML Prefilled Syringe [Durolane]


cobicistat 150 MG / darunavir 800 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet


exenatide 2 MG per 0.85 mL Auto-Injector

0.85 ML exenatide 2.35 MG/ML Auto-Injector


RETIN-A MICRO 0.06 % Topical Gel
Retin-A Micro 0.06 % Topical Gel
Retin-A 0.0006 MG/MG Topical Gel

tretinoin 0.0006 MG/MG Topical Gel [Retin-A]


lidocaine hydrochloride 40 MG/ML Topical Solution

lidocaine hydrochloride 4 % Topical Solution


bosutinib 400 MG (as bosutinib monohydrate 413.6 MG) Oral Tablet


Bosulif 400 MG (as bosutinib monohydrate 413.6 MG) Oral Tablet


dilTIAZem hydrochloride 120 MG [Tiadylt]

diltiazem hydrochloride 120 MG [Tiadylt]


dilTIAZem Extended Release Oral Capsule [Tiadylt]

diltiazem Extended Release Oral Capsule [Tiadylt]


24 HR dilTIAZem hydrochloride 120 MG Extended Release Oral Capsule [Tiadylt]

24 HR Tiadylt 120 MG Extended Release Oral Capsule

24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule [Tiadylt]


dilTIAZem hydrochloride 180 MG [Tiadylt]

diltiazem hydrochloride 180 MG [Tiadylt]


24 HR dilTIAZem hydrochloride 180 MG Extended Release Oral Capsule [Tiadylt]

24 HR Tiadylt 180 MG Extended Release Oral Capsule

24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule [Tiadylt]


dilTIAZem hydrochloride 240 MG [Tiadylt]

diltiazem hydrochloride 240 MG [Tiadylt]


24 HR Tiadylt 240 MG Extended Release Oral Capsule

24 HR dilTIAZem hydrochloride 240 MG Extended Release Oral Capsule [Tiadylt]

24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule [Tiadylt]


dilTIAZem hydrochloride 300 MG [Tiadylt]

diltiazem hydrochloride 300 MG [Tiadylt]


24 HR dilTIAZem hydrochloride 300 MG Extended Release Oral Capsule [Tiadylt]

24 HR Tiadylt 300 MG Extended Release Oral Capsule

24 HR diltiazem hydrochloride 300 MG Extended Release Oral Capsule [Tiadylt]


dilTIAZem hydrochloride 360 MG [Tiadylt]

diltiazem hydrochloride 360 MG [Tiadylt]


24 HR dilTIAZem hydrochloride 360 MG Extended Release Oral Capsule [Tiadylt]

TIADYLT ER 360 MG 24HR Extended Release Oral Capsule

24 HR Tiadylt 360 MG Extended Release Oral Capsule

24 HR diltiazem hydrochloride 360 MG Extended Release Oral Capsule [Tiadylt]


dilTIAZem hydrochloride 420 MG [Tiadylt]

diltiazem hydrochloride 420 MG [Tiadylt]


24 HR dilTIAZem hydrochloride 420 MG Extended Release Oral Capsule [Tiadylt]

24 HR Tiadylt 420 MG Extended Release Oral Capsule

24 HR diltiazem hydrochloride 420 MG Extended Release Oral Capsule [Tiadylt]


latanoprostene bunod Ophthalmic Solution


latanoprostene bunod 0.024 % Ophthalmic Solution

latanoprostene bunod 0.24 MG/ML Ophthalmic Solution


latanoprostene bunod 0.24 MG/ML [Vyzulta]


latanoprostene bunod Ophthalmic Solution [Vyzulta]


Vyzulta 0.024 % Ophthalmic Solution
Vyzulta 0.24 MG/ML Ophthalmic Solution
VYZULTA 0.024 % Ophthalmic Solution

latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [Vyzulta]


piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML [Herklin]


piperonyl butoxide / pyrethrins Medicated Shampoo [Herklin]


Herklin (piperonyl butoxide 4 % / pyrethrins 0.33 % ) Medicated Shampoo

piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML Medicated Shampoo [Herklin]


Tolcylen 10 MG/ML Topical Solution
Tolcylen 1 % Topical Solution

tolnaftate 10 MG/ML Topical Solution [Tolcylen]


chervil root oil
Chaerophyllum bulbosum (root) oil


pitavastatin 1 MG (as pitavastatin magnesium 1.026 MG) Oral Tablet


pitavastatin 2 MG (as pitavastatin magnesium 2.053 MG) Oral Tablet


pitavastatin 4 MG (as pitavastatin magnesium 4.106 MG) Oral Tablet